Rockefeller Capital Management L.P. grew its holdings in Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) by 45.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 36,500 shares of the company's stock after acquiring an additional 11,366 shares during the quarter. Rockefeller Capital Management L.P.'s holdings in Celsius were worth $961,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of Celsius by 2.2% during the fourth quarter. Vanguard Group Inc. now owns 15,813,110 shares of the company's stock worth $416,517,000 after buying an additional 345,837 shares during the period. Alliancebernstein L.P. lifted its stake in Celsius by 11.2% in the 4th quarter. Alliancebernstein L.P. now owns 14,292,123 shares of the company's stock valued at $376,455,000 after acquiring an additional 1,444,020 shares in the last quarter. FMR LLC boosted its position in Celsius by 64.2% during the 4th quarter. FMR LLC now owns 4,055,148 shares of the company's stock worth $106,813,000 after acquiring an additional 1,585,839 shares during the last quarter. Contrarius Group Holdings Ltd bought a new position in shares of Celsius during the 4th quarter worth approximately $75,535,000. Finally, Norges Bank bought a new stake in shares of Celsius in the fourth quarter worth $72,579,000. Institutional investors and hedge funds own 60.95% of the company's stock.
Insiders Place Their Bets
In other news, insider Paul H. Storey sold 10,188 shares of Celsius stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $25.77, for a total value of $262,544.76. Following the completion of the sale, the insider now directly owns 45,297 shares in the company, valued at approximately $1,167,303.69. The trade was a 18.36 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Joyce Russell sold 4,000 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $28.47, for a total value of $113,880.00. Following the sale, the director now directly owns 19,106 shares in the company, valued at $543,947.82. This represents a 17.31 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.20% of the company's stock.
Celsius Stock Performance
CELH traded down $0.46 on Friday, reaching $36.74. The company had a trading volume of 4,853,692 shares, compared to its average volume of 7,781,064. The stock has a market cap of $9.47 billion, a P/E ratio of 83.50, a P/E/G ratio of 2.90 and a beta of 1.58. Celsius Holdings, Inc. has a fifty-two week low of $21.10 and a fifty-two week high of $98.85. The company's fifty day moving average is $32.40 and its 200 day moving average is $29.53.
Celsius (NASDAQ:CELH - Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.11 by $0.03. The company had revenue of $332.20 million for the quarter, compared to the consensus estimate of $326.07 million. Celsius had a return on equity of 51.89% and a net margin of 10.70%. On average, sell-side analysts expect that Celsius Holdings, Inc. will post 0.89 EPS for the current year.
Analysts Set New Price Targets
A number of research analysts recently weighed in on CELH shares. UBS Group raised their target price on shares of Celsius from $43.00 to $48.00 and gave the company a "buy" rating in a research report on Thursday, April 17th. LADENBURG THALM/SH SH decreased their price objective on Celsius from $62.00 to $58.00 and set a "neutral" rating for the company in a report on Thursday, March 27th. Stifel Nicolaus dropped their target price on Celsius from $45.00 to $37.00 and set a "buy" rating on the stock in a report on Monday, February 10th. B. Riley restated a "buy" rating and issued a $49.00 price target (up from $44.00) on shares of Celsius in a research note on Friday, February 21st. Finally, Piper Sandler upped their price objective on Celsius from $43.00 to $44.00 and gave the stock an "overweight" rating in a research note on Thursday, April 17th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $46.47.
Get Our Latest Report on Celsius
Celsius Company Profile
(
Free Report)
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Featured Stories

Before you consider Celsius, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.
While Celsius currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.